Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Evolving Motivations: Patients' and Caregivers' Perceptions About Seeking Myotonic Dystrophy (DM1) and Huntington's Disease Care.

LaDonna KA, Watling CJ, Ray SL, Piechowicz C, Venance SL.

Qual Health Res. 2017 Sep;27(11):1727-1737. doi: 10.1177/1049732317711901. Epub 2017 Jun 19.

PMID:
28799481
2.

Survey of Canadian Myotonic Dystrophy Patients' Access to Computer Technology.

Climans SA, Piechowicz C, Koopman WJ, Venance SL.

Can J Neurol Sci. 2017 Sep;44(5):567-571. doi: 10.1017/cjn.2017.47. Epub 2017 May 24.

PMID:
28535832
3.

Approach to the Patient With HyperCKemia.

Venance SL.

Continuum (Minneap Minn). 2016 Dec;22(6, Muscle and Neuromuscular Junction Disorders):1803-1814. Review.

PMID:
27922494
4.

Myotonic Dystrophy and Huntington's Disease Care: "We Like to Think We're Making a Difference".

LaDonna KA, Watling CJ, Ray SL, Piechowicz C, Venance SL.

Can J Neurol Sci. 2016 Sep;43(5):678-86. doi: 10.1017/cjn.2016.257.

PMID:
27670211
5.

Pompe Disease: Diagnosis and Management. Evidence-Based Guidelines from a Canadian Expert Panel.

Tarnopolsky M, Katzberg H, Petrof BJ, Sirrs S, Sarnat HB, Myers K, Dupré N, Dodig D, Genge A, Venance SL, Korngut L, Raiman J, Khan A.

Can J Neurol Sci. 2016 Jul;43(4):472-85. doi: 10.1017/cjn.2016.37. Epub 2016 Apr 8. Review.

PMID:
27055517
6.

Hard to Swallow: A Phenomenological Exploration of the Experience of Caring for Individuals With Myotonic Dystrophy and Dysphagia.

LaDonna KA, Koopman WJ, Ray SL, Venance SL.

J Neurosci Nurs. 2016 Feb;48(1):42-51. doi: 10.1097/JNN.0000000000000178.

PMID:
26720320
7.

Picturing the Experience of Living With Myotonic Dystrophy (DM1): A Qualitative Exploration Using Photovoice.

LaDonna KA, Venance SL.

J Neurosci Nurs. 2015 Oct;47(5):285-95. doi: 10.1097/JNN.0000000000000160.

PMID:
26348433
8.

Truths and misinformation: a qualitative exploration of myotonic dystrophy.

LaDonna KA, Ghavanini AA, Venance SL.

Can J Neurol Sci. 2015 May;42(3):187-94. doi: 10.1017/cjn.2015.26. Epub 2015 Apr 13.

PMID:
25867706
9.

Intravenous immunoglobulin response in treatment-naïve chronic inflammatory demyelinating polyradiculoneuropathy.

Kuitwaard K, Hahn AF, Vermeulen M, Venance SL, van Doorn PA.

J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1331-6. doi: 10.1136/jnnp-2014-309042. Epub 2014 Dec 16.

PMID:
25515502
10.

Exploring frontline faculty perspectives after a curriculum change.

Venance SL, LaDonna KA, Watling CJ.

Med Educ. 2014 Oct;48(10):998-1007. doi: 10.1111/medu.12529.

PMID:
25200020
11.

The CNDR: collaborating to translate new therapies for Canadians.

Korngut L, Campbell C, Johnston M, Benstead T, Genge A, Mackenzie A, McCormick A, Biggar D, Bourque P, Briemberg H, O'Connell C, Dojeiji S, Dooley J, Grant I, Hogan G, Johnston W, Kalra S, Katzberg HD, Mah JK, McAdam L, McMillan HJ, Melanson M, Selby K, Shoesmith C, Smith G, Venance SL, Wee J; CNDR Investigator Network.

Can J Neurol Sci. 2013 Sep;40(5):698-704.

PMID:
23968944
12.

Non-dystrophic myotonia: prospective study of objective and patient reported outcomes.

Trivedi JR, Bundy B, Statland J, Salajegheh M, Rayan DR, Venance SL, Wang Y, Fialho D, Matthews E, Cleland J, Gorham N, Herbelin L, Cannon S, Amato A, Griggs RC, Hanna MG, Barohn RJ; CINCH Consortium.

Brain. 2013 Jul;136(Pt 7):2189-200. doi: 10.1093/brain/awt133. Epub 2013 Jun 13.

13.

Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial.

Statland JM, Bundy BN, Wang Y, Rayan DR, Trivedi JR, Sansone VA, Salajegheh MK, Venance SL, Ciafaloni E, Matthews E, Meola G, Herbelin L, Griggs RC, Barohn RJ, Hanna MG; Consortium for Clinical Investigation of Neurologic Channelopathies.

JAMA. 2012 Oct 3;308(13):1357-65. doi: 10.1001/jama.2012.12607.

14.

A quantitative measure of handgrip myotonia in non-dystrophic myotonia.

Statland JM, Bundy BN, Wang Y, Trivedi JR, Raja Rayan D, Herbelin L, Donlan M, McLin R, Eichinger KJ, Findlater K, Dewar L, Pandya S, Martens WB, Venance SL, Matthews E, Amato AA, Hanna MG, Griggs RC, Barohn RJ; CINCH Consortium.

Muscle Nerve. 2012 Oct;46(4):482-9. doi: 10.1002/mus.23402.

15.

Decomposition-based quantitative electromyography in the evaluation of muscular dystrophy severity.

Derry KL, Venance SL, Doherty TJ.

Muscle Nerve. 2012 Apr;45(4):507-13. doi: 10.1002/mus.22341.

PMID:
22431083
16.

Myotonic dystrophy (DM1) and dysphagia: the need for dysphagia management guidelines and an assessment tool.

LaDonna KA, Koopman WJ, Venance SL.

Can J Neurosci Nurs. 2011;33(1):42-6. Review.

PMID:
21560885
17.

Clinical features of facioscapulohumeral muscular dystrophy 2.

de Greef JC, Lemmers RJ, Camaño P, Day JW, Sacconi S, Dunand M, van Engelen BG, Kiuru-Enari S, Padberg GW, Rosa AL, Desnuelle C, Spuler S, Tarnopolsky M, Venance SL, Frants RR, van der Maarel SM, Tawil R.

Neurology. 2010 Oct 26;75(17):1548-54. doi: 10.1212/WNL.0b013e3181f96175.

18.

The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.

Matthews E, Fialho D, Tan SV, Venance SL, Cannon SC, Sternberg D, Fontaine B, Amato AA, Barohn RJ, Griggs RC, Hanna MG; CINCH Investigators.

Brain. 2010 Jan;133(Pt 1):9-22. doi: 10.1093/brain/awp294. Epub 2009 Nov 16. Review.

19.

Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD.

de Greef JC, Lemmers RJ, van Engelen BG, Sacconi S, Venance SL, Frants RR, Tawil R, van der Maarel SM.

Hum Mutat. 2009 Oct;30(10):1449-59. doi: 10.1002/humu.21091.

PMID:
19728363
20.

Phenotype of combined Duchenne and facioscapulohumeral muscular dystrophy.

Korngut L, Siu VM, Venance SL, Levin S, Ray P, Lemmers RJ, Keith J, Campbell C.

Neuromuscul Disord. 2008 Jul;18(7):579-82. doi: 10.1016/j.nmd.2008.03.011. Epub 2008 Jun 30.

PMID:
18586493

Supplemental Content

Loading ...
Support Center